Hostess Brands $106 Million Secondary Offering
Davis Polk advised the sole bookrunner in connection with the $106.48 million SEC-registered secondary offering of 8,000,000 shares of Class A common stock of Hostess Brands, Inc. by…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Applied Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $40 million initial public offering of common stock of Applied Therapeutics, Inc. Applied…
Bristol-Myers Squibb Company $19 Billion Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $19 billion in aggregate principal amount of senior notes by Bristol-Myers…
Roku, Inc. SEC-Registered At-The-Market Offering
Davis Polk advised the agent bank on the SEC-registered at-the-market offering by Roku, Inc. of up to 1,000,000 shares of its Class A common stock.
Roku pioneered streaming to the TV and is…
Davis Polk Advises Tencent on Its Strategic Investment in JD.com
Davis Polk is advising Tencent in connection with its purchase of additional Class A ordinary shares to be issued by JD.com and the renewal of their strategic cooperation agreement for…
Gold Fields $1 Billion Notes Offering and Cash Tender Offer
Davis Polk advised the joint active bookrunners and representatives of the several initial purchasers in connection with a Rule 144A/Regulation S offering of notes by Gold Fields Orogen…
IBM $20 Billion Notes Offering
Davis Polk advised the representatives of the underwriters in connection with a public offering by International Business Machines Corporation of $1.5 billion aggregate principal amount of…
Davis Polk Advises Nederlandse Waterschapsbank Bank N.V. on Its €60 Billion Debt Issuance Program Update
Davis Polk advised Nederlandse Waterschapsbank Bank N.V. in connection with the annual update of its €60 billion Rule 144A/Regulation S debt issuance program. In the 12 months prior to the…
Intercept Pharmaceuticals, Inc. Concurrent $231 Million Common Stock Offering and $230 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 2,760,000 shares of common stock of Intercept Pharmaceuticals, Inc. …
Uber Technologies $8.1 billion IPO
Davis Polk advised the underwriters in connection with the $8.1 billion initial public offering of 180,000,000 shares of common stock of Uber Technologies, Inc. Uber’s common stock is…